{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:47:56Z","timestamp":1760888876095},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11596-013-1208-6","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T00:16:26Z","timestamp":1386807386000},"page":"840-844","source":"Crossref","is-referenced-by-count":5,"title":["Reversal effect of BM-cyclin 1 on multidrug resistance by down-regulating MRP2 in BALB\/C nude mice bearing C-A120 cells"],"prefix":"10.1007","volume":"33","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaofeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jizhen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,13]]},"reference":[{"issue":"5","key":"1208_CR1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00001622-200009000-00011","volume":"12","author":"B Tan","year":"2000","unstructured":"Tan B, Piwnica-Worms D, Ratner L. Multidrug resistance transporters and modulation. Curr Opi Oncol, 2000, 12(5):450\u2013458","journal-title":"Curr Opi Oncol"},{"issue":"5","key":"1208_CR2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1734-1140(12)70900-3","volume":"64","author":"KM Stepien","year":"2012","unstructured":"Stepien KM, Tomaszewski M, Tomaszewska J, et al. The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs. Pharmacol Rep, 2012, 64(5):1011\u20131019","journal-title":"Pharmacol Rep"},{"issue":"8","key":"1208_CR3","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0306-3623(96)00081-X","volume":"27","author":"O Fardel","year":"1996","unstructured":"Fardel O, Lecureur V, Guillouzo A. The P-glycoprotein multidrug transporter. Gen Pharmacol, 1996,27(8): 1283\u20131291","journal-title":"Gen Pharmacol"},{"issue":"6","key":"1208_CR4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/cmdc.201000006","volume":"5","author":"L Zhang","year":"2010","unstructured":"Zhang L, Ma S. Efflux pump inhibitors: a strategy to combat P-glycoprotein and the NorA multidrug resistance pump. Chem Med Chem, 2010,5(6):811\u2013822","journal-title":"Chem Med Chem"},{"issue":"16","key":"1208_CR5","first-page":"3537","volume":"57","author":"M Kool","year":"1997","unstructured":"Kool M, de Haas M, Scheffer GL, et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res, 1997,57(16):3537\u20133547","journal-title":"Cancer Res"},{"issue":"10","key":"1208_CR6","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.3390\/md10102312","volume":"10","author":"I Abraham","year":"2012","unstructured":"Abraham I, El Sayed K, Chen ZS, et al. Current status on marine products with reversal effect on cancer multidrug resistance. Mar Drugs, 2012,10(10):2312\u20132321","journal-title":"Mar Drugs"},{"issue":"1","key":"1208_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/bse0500179","volume":"50","author":"AJ Slot","year":"2011","unstructured":"Slot AJ, Molinski SV, Cole SP. Mammalian multidrug-resistance proteins (MRPs). Essays in Biochem, 2011,50(1):179\u2013207","journal-title":"Essays in Biochem"},{"issue":"3","key":"1208_CR8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/17425255.2.3.351","volume":"2","author":"G Jedlitschky","year":"2006","unstructured":"Jedlitschky G, Hoffmann U, Kroemer HK. Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert Opin Drug Metab Toxicol, 2006,2(3):351\u2013366","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"1208_CR9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02257459","volume":"20","author":"T Sumizawa","year":"1994","unstructured":"Sumizawa T, Chuman Y, Sakamoto H, et al. Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine, and mezerein. Somat Cell Mol Genet, 1994,20(5):423\u2013435","journal-title":"Somat Cell Mol Genet"},{"issue":"9","key":"1208_CR10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/CAD.0b013e328223f14d","volume":"18","author":"L Wang","year":"2007","unstructured":"Wang L, Sun J, Li YQ, et al. Reversal effect of BM-cyclin 1 on multidrug resistance in C-A120 cells. Anti-cancer Drugs, 2007,18(9):1015\u20131021","journal-title":"Anti-cancer Drugs"},{"issue":"2","key":"1208_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1368-7646(03)00005-0","volume":"6","author":"A Sparreboom","year":"2003","unstructured":"Sparreboom A, Danesi R, Ando Y, et al. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. Drug Resist Updat, 2003,6(2):71\u201384","journal-title":"Drug Resist Updat"},{"issue":"5088","key":"1208_CR12","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","volume":"258","author":"SP Cole","year":"1992","unstructured":"Cole SP, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 1992,258(5088):1650\u20131654","journal-title":"Science"},{"issue":"6","key":"1208_CR13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1012866803188","volume":"33","author":"MM Gottesman","year":"2001","unstructured":"Gottesman MM, Ambudkar SV. Overview: ABC transporters and human disease. J Bioenerg Biomembr, 2001,33(6):453\u2013458","journal-title":"J Bioenerg Biomembr"},{"issue":"2","key":"1208_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","volume":"10","author":"H Thomas","year":"2003","unstructured":"Thomas H, Coley HM. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control, 2003,10(2):159\u2013165","journal-title":"Cancer Control"},{"issue":"3","key":"1208_CR15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11596-010-0351-6","volume":"30","author":"Q Chen","year":"2010","unstructured":"Chen Q, Zhou J, Jiang C, et al. Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901\/VCR cells by PPAR\u0393 activation by troglitazone. J Huazhong Univ Sci Technol Med Sci, 2010,30(3):326\u2013331","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"9","key":"1208_CR16","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1128\/AAC.47.9.2892-2896.2003","volume":"47","author":"J Bosling","year":"2003","unstructured":"Bosling J, Poulsen SM, Vester B, et al. Resistance to the peptidyl transferase inhibitor tiamulin caused by mutation of ribosomal protein l3. Antimicrob Agents Chemother, 2003,47(9):2892\u20132896","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1208_CR17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1128\/AAC.19.2.260","volume":"19","author":"G Hogenauer","year":"1981","unstructured":"Hogenauer G, Ruf C. Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs. Antimicrob Agents Chemother, 1981,19(2):260\u2013265","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1208_CR18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s001200050038","volume":"35","author":"GH Mickisch","year":"1996","unstructured":"Mickisch GH, Multidrug resistance. 18 Mickisch GH, Multidrug resistance. Urologe A, 1996,35(5):370\u2013377","journal-title":"Urologe A"},{"issue":"8","key":"1208_CR19","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.bcp.2003.12.032","volume":"67","author":"JJ Zanden van","year":"2004","unstructured":"van Zanden JJ, Geraets L, Wortelboer HM, et al. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem Pharmacol, 2004,67(8):1607\u20131617","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1208_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3835(98)00083-4","volume":"129","author":"Y Chuman","year":"1998","unstructured":"Chuman Y, Chen ZS, Seto K, et al. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P. Cancer Lett, 1998,129(1):69\u201376","journal-title":"Cancer Lett"},{"issue":"3","key":"1208_CR21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1006\/bbrc.1997.7015","volume":"236","author":"ZS Chen","year":"1997","unstructured":"Chen ZS, Mutoh M, Sumizawa T, et al. Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells. Biochem Biophys Res Commun, 1997,236(3):586\u2013590","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-013-1208-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-013-1208-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-013-1208-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T20:25:06Z","timestamp":1564950306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-013-1208-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1007\/s11596-013-1208-6","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}